P-344 - SALVAGE RADIOTHERAPY IN PATIENTS WITH BIOCHEMICAL RELAPSE AFTER RADICAL PROSTATECTOMY
P-345 - SALVAGE SBRT FOR OLIGORECURRENT LYMPH NODE PROSTATE CANCER METASTASES.
P-347 - SBRT para lesiones mĂșltiples: control tumoral y toxicidad
P-348 - SBRT ADRENAL METASTASES TREATED IN TOMOTHERAPY
P-349 - SBRT FOR EARLY-STAGE LUNG CANCER AND LUNG OLIGOMETASTASES. OUR EXPERIENCE
P-350 - SBRT FOR INOPERABLE EARLY STAGE LUNG CANCER. RETROSPECTIVE ANALYSIS.
P-351 - SBRT FOR LYMPH NODE OLIGOMETASTASES FROM PROSTATE CANCER
P-352 - SBRT FOR TREATMENT OF OLIGOMETASTATIC PROSTATE CANCER
P-353 - SBRT IN CARDIAC SARCOMA
P-354 - SBRT IN HIGH-INTERMEDIATE RISK PROSTATE CANCER
P-356 - SBRT IN NODAL OLIGORECURRENCE PROSTATE CANCER: BIOCHEMICAL PROGRESSION FREE SURVIVAL
P-357 - SBRT IN THE TREATMENT OF LIVER METASTASES.
P-358 - SBRT VERSUS SURGERY FOR LUNG METASTASES FROM CRC: SINGLE-INSTITUTION RESULTS
P-359 - SBRT-PATHY AS A NEW PLAYER IN UNRESECTABLE NSCLC: FIRST REPORTED CASE
P-360 - SCLEREDORMA AND NASOPHARINGE CANCER
P-361 - SCREENING AND EARLY DETECTION OF MALNUTRITION IN ONCOLOGY PATIENTS
P-362 - SECOND CONSERVATIVE TREATMENT FOR SECOND IPSILATERAL BREAST TUMOR EVENT
P-363 - SEXUAL CONCERNS IN CANCER PATIENTS IN A TERTIARY CENTER.
P-364 - SGRT ANALYSIS ACCURACY FOR INTRAFRACTION CONTROL IN LUNG SBRT
P-365 - SHIFT EVALUATION WITH IDENTIFY SGRT SYSTEM
P-366 - SARS-COV-2 IMPACT ON THE DIAGNOSIS AND STAGING OF RECTAL CANCER